IP Library Assignment 044085/0924
Patent Assignment
Reel/Frame 044085/0924

Assignment of Assignor's Interest

Recorded: 2017-11-09 Pages: 11
Assignor
VIROPHARMA HOLDINGS LIMITED
Executed: 2017-09-28
Assignee
SHIRE VIROPHARMA INCORPORATED
300 SHIRE WAY, LEXINGTON, MASSACHUSETTS, 02421
Covered Property (1)
Methods of Treating Antibody-Mediated Rejection in Organ Transplant Patients with C1-Esterase Inhibitor
Patent: 9,895,428 →
Application: 14/550,075 →
Publication: US 2015/0147319
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 17, 2015
From: UKNIS, MARC E.
To: VIROPHARMA HOLDINGS LIMITED
Reel/Frame 036122/0865 →
Assignment of Assignor's Interest Aug 21, 2015
From: DUOCORT PHARMA AB; VIROPHARMA HOLDINGS LIMITED
To: SHIRE VIROPHARMA INCORPORATED
Reel/Frame 036393/0679 →
Assignment of Assignor's Interest Nov 9, 2017
From: UKNIS, MARC E.
To: VIROPHARMA HOLDINGS LIMITED
Reel/Frame 044085/0884 →
Assignment of Assignor's Interest Nov 9, 2017
From: BROOM, COLIN; UKNIS, MARC E.
To: VIROPHARMA HOLDINGS LIMITED
Reel/Frame 044085/0908 →
Assignment of Assignor's Interest May 20, 2021
From: SHIRE VIROPHARMA LLC
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 056307/0254 →
Change of Name Jun 15, 2021
From: SHIRE VIROPHARMA INCORPORATED
To: SHIRE VIROPHARMA LLC
Reel/Frame 056596/0380 →